Indeed, satellite cell-mediated induction of the fetal gene program and associated sarcolemmal instability in myofibers during MD could represent more specific therapeutic targets of value, especially as we define the most critical molecular effectors of these disease processes (such as MyoD and membrane altering genes). Here, MYOD1 is linked to Menkes disease.